The presence of a t(11;22)(q24;q12) translocation is one of the characteristic features of the Ewing family of tumors. The detection of the fusion gene product by RT-PCR using primers at both sides of the breakpoints has been advocated as a diagnostic tool. By applying this technique appropriate internal controls are required. We found that the use of normal non-rearranged EWS mRNA as an internal control for RNA quality may lead to conflicting data. We obtained PCR products of the expected size for the normal EWS mRNA in both RNA and DNA samples, suggesting the existence of one or more EWS pseudogenes. A 109 bp sequence at the 5' end of this PCR-product contained a correctly spliced exon junction and was 97% homologous to the EWS cDNA sequence. Similarly two such junctions were found in a 346 bp sequence of the 3' end, which was 89% homologous. Hence EWS should not be used as an internal control for the RNA quality in a RT-PCR based test for the presence of the tranSlOCation.
cases (6) (7) (8) (9) . The breakpoint has been cloned (10) and the two genes involved, FLU on chromosome 11q24 and EWS on chromosome 22q12, were identified (11, 12) . Several reports have described the RT-PCR detection of the resulting EWS-FLI1 fusion transcript as a valuable diagnostic tool to identify Ewing's sarcoma and PNET within the other small blue round cell tumors (13) (14) (15) (16) (17) . Using this technique even fusion transcripts resulting from subtle structural abnormalities of 11q24 and 22q12 not found by cytogenetic analysis can be detected.
The EWS-FLI1 fusion transcript can be identified in up to 95% of Ewing's sarcoma and PNET (18) . In the remaining percentage of these tumors another translocation, t(21;22)(q22;q12), is found, resulting in an EWS-ERG fusion transcript which can also be detected by RT-PCR (18) (19) (20) . Detection of the fusion transcript is highly specific since several other tumors, including rhabdomyosarcomas, small cell osteosarcomas and neuroblastomas are negative (13, (15) (16) (17) . We applied the RT-PCR translocation detection method as described (13) (14) (15) (16) (17) (18) for implementation in routine diagnostic procedures. In this manuscript we demonstrate that the use of the wild type EWS gene, recommended as a control for RNA quality by Delattre et al (18) , may lead to spurious signals when the RNA sample is contaminated with DNA. Pre-treatment of RNA with RNAse or DNAse before RT-PCR resulted in the identification of a novel EWS related product which turned out to be most likely an intronless EWS pseudogene.
Since it is difficult to discriminate between PCR products of EWS-RNA and the EWS-pseudogene, false negative diagnoses may result from these misleading signals.
METHODS
Patient material: Snap frozen tissue, stored at -80°C, of 7 Ewing's sarcomas and several other tumors was studied. The diagnosis Ewing's sarcoma was based on histological, clinical-radiological and immunohistochemical data; all 7 cases studied showed immunoreactivity for the 013 antibody directed against the MIC2 protein. In addition, we used a Ewing's sarcoma cell-culture with cytogenetically proven t(11;22)(q24;q12) as a positive control. As a control for specificity, irrelevant normal, or tumoral tissue was used of 1 5 patients (including normal colon, ovarian carcinoma, melanoma of the eye, cervical carcinoma, papillary thyroid carcinoma, colon carcinoma, carcinoma of the breast, squamous cell carcinoma, rhabdomyosarcoma and small cell osteosarcoma).
DNA and RNA extraction: Total RNA extraction was performed with TRIzol (Gibco BRL Life Technologies, Gaithersburg, MD, USA) according to the manufacturer's recommendation. This commercial guanidinium/phenol based reagent is claimed to be an improvement to the single-step RNA isolation method developed by Chomczynski and Sacchi (21) . 15 sections of 20 /ym of snap frozen tissue were cut using a microtome. The microtome blade was thoroughly cleaned with 70% ethanol between cutting of individual specimens to minimize cross contamination. A cell suspension of 6x10 6 cultured Ewing sarcoma cells was centrifuged and the pellet was used for RNA isolation. DNA isolation from irrelevant freshly collected blood samples was performed according to the method of Miller et al (22) . The DNA and RNA concentration and purity was determined by measuring the absorption at 260 and 280 nm at a spectrophotometer (Ultrospec plus, LKB Biochrom, Bromma, Sweden).
Reverse transcription: One or two fjg of total RNA was reverse transcribed using 100 ng oligo dT (Boehringer Mannheim, Germany) in a total volume of 20 //I containing 1U RNAsin, 1 mM dNTP, 100 mM Tris-HCI, pH 8.3, 80 mM KCI, 12 mM MgCI 2 , 2 mM DTT and 5U AMV-reverse transcriptase (Boehringer Mannheim, Germany). The tubes were incubated at 37°C for 1 hour. cDNAs were stored at -20°C.
Polymerase Chain Reaction: One //I of the resulted cDNA was used directly for amplification. PCR was performed in a total volume of 50 jj\, containing 30 pmol of each primer, 0.2 mM dNTP (all purchased from Pharmacia, Woerden, the Netherlands), 50 mM KCI, 10 mM Tris (pH 8.3), 0.2 mg/ml Bovine Serum Albumin (BSA), 2 mM MgCI 2 and 1U Ampli-Taq (Perkin Elmer, Norwalk, CT, USA). All standard precautions were taken to prevent contamination during PCR-reaction. Thermal cycling was performed in a programmable heat block (Perkin Elmer Cetus, Norwalk, CT, USA). The amplification conditions for all primer sets used were as described (18); 30 cycles with each cycle consisting of denaturation at 94°C for 30 sec, annealing at 68°C for 1 min and elongation at 72°C for 1 min. Ten //I of each PCR-product was subjected to electrophoresis in 1.2% agarose gels. A 100 bp length marker (Gibco BRL, Life Technologies, Gaithersburg, MD, USA) was used to estimate the sizes of the obtained PCRproducts. Amplification products were visualized by staining with ethidium bromide. To test for the presence of the EWS-FLI1 hybrid transcript, amplification was carried out with primers 22.8 and 11.11. These primers were prepared according to published sequences (18, 20) . EWS-FLI1 fusion PCR products vary in sizes ranging from 205 to 820 basepairs (12) (13) (14) .
Controls: For confirmation that each RNA sample tested could potentially yield products after RT-PCR, transcripts of the wild type EWS or the housekeeping gene HPRT were amplified simultaneously under the same conditions as demanded for detection of fusion transcripts. For amplification of part of the wild type EWS cDNA, the same EWS forward primer (22.8) was used in combination with a reverse primer (22.4) (18). HPRT cDNA was amplified with primers hum1 (5'-ACCGGCTTCCTCCTCCTGAGCAGTC-3') and hum2 (5'AG-GACTCCAGATGTTTCCAAACTCAACTT-3'). To exclude PCR products resulting from DNA rather than RNA, two approaches were used. First, to test for the presence of contaminating genomic DNA in the RNA samples, each RNA sample was also incubated with a similar mixture without addition of AMV reverse transcriptase. Second, RNAse and DNAse treatments were performed; 2 fjg of total RNA or DNA were treated with 1U RQ1 RNAse-free-DNAse (Promega, Madison, Wl, USA) or RNAse (Stratagene, La Jolla, CA, USA) in a total volume of 12 fj\ containing 50 mM KCI, 10 mM Tris (pH 8.3), 0.2 mg/ml BSA, 2.5 mM MgCI 2 and 40 U RNAsin (Promega, Madison, Wl, USA). Samples were incubated at 37°C for 1 hour and DNAse was inactivated by incubation at 80°C for 10 min. As a positive control for the EWS-FLI1 fusion transcript, RNA of cultured Ewing cells, with cytogenetically confirmed t(11;22) was included in each test. As a negative control H 2 0 was used as a template in each test to exclude contamination of primers, water or reagents.
Sequence analysis: The approximately 1200 bp PCR product that resulted from amplification of genomic DNA using M13-tailed primers 22.4 and 22.8 (CGAC-GTTGTAAAACGACGGCCAGT-22.8 and CAGGAAACAGCTATGAC-22.4) was sequenced. A second PCR was done with biotin labeled M13 primers using the product of the first PCR as template. The resulting PCR products were purified using the EasyPrep kit (Pharmacia Biotech, Uppsala, Sweden) according to the manufacturer's recommendations. PCR products were alkali-denatured and single-strand fragments were captured using Dynabeads (ITK diagnostics, Uithoorn, the Netherlands). Sequencing reactions were performed on the Automated Laser Fluorescence DNA sequencer (Pharmacia Biotech, Uppsala, Sweden) according to the manufacturer's recommendations for the Autoread kit (Pharmacia biotech, Uppsala, Sweden). Computer assisted analysis of the obtained results was performed. Another approach was made using primers 22.4 and 22.8 (without M13 tails) which were radioactively labeled with [
32 P]-dATP using T4 polynucleotide kinase. Sequencing was performed using the USB cycle sequencing kit (U.S.B., Cleveland, Ohio, USA) and thermal cycling took place in a programmable heatblock (Perkin Elmer, Norwalk, CT, USA) with 30 cycles consisting of annealing at 65°C and denaturation at 95°C. Samples were subjected to electrophoresis on standard denaturing 6% polyacrylamide gels containing 7M urea. Autoradiography was performed by exposition to X-ray films (Kodak) for 24-72 hours. Nucleotide sequences were determined by visual inspection. Obtained sequences were not verified by sequencing the opposite strand.
RESULTS
Reverse transcription and PCR reaction: In all seven Ewing's sarcomas tested and the Ewing's cells in culture with a proven t(11;22), EWS-FLI1 fusion transcripts were detected (Fig.1) . No products were seen in the negative controls (H 2 0) as well as in 15 carcinomas and sarcomas not belonging to the Ewing tumor family. The EWS internal control yielded a PCR product of the size as expected from previous studies (18) in all RNA samples tested. However, omission of reverse transcriptase, amplification of genomic DNA and pretreatment of DNA with RNAse revealed a product of the same size ( Fig. 2A) .
After DNAse pretreatment of RNA samples, no PCR product was obtained anymore. These results indicate that the obtained products resulted from amplification of DNA, instead of reverse transcribed RNA. When we used the hypoxanthine phosphoribosyltransferase (HPRT) control as suggested by Foss et al (23) , PCR products of the expected size (747 bp) were obtained only when RNA, after reverse transcription, was used as template (Fig. 2B) . After RT-PCR analysis of Ewing's sarcomas. Total RNA was extracted from archival fresh frozen tumor tissue, followed by RT-PCR analysis using primers on exon 7 of EWS and exon 9 on FLU. Products were electrophoresed on a 1.2% agarose gel and visualized by staining with ethidium bromide. 1-7: Ewing's sarcomas, + : Ewing's sarcoma with cytogenetically proven t(11;22)(q24;q12), bl: H 2 O as a negative control, L: 100 bp size marker. pretreatment of DNA with RNAse and with omission of reverse transcriptase, no PCR product could be obtained.
Sequence analysis:
From both the 5' and the 3' end of the EWS PCR product a partial nucleotide sequence could be obtained (Fig. 3) . A sequence of 109 basepairs was obtained using the forward primer which showed 97% homology to the published sequence of the EWS-cDNA (12) . In this region a correctly spliced junction between exons 7 and 8 in EWS (24) control with a negative result for the fusion product determines that the diagnosis should be reconsidered.
In this manuscript we report the existence of an EWS pseudogene. Pseudogenes are homologs of active genes but they do not contain any of the introns and a polyA tail at the 3'-end can be found (25) . Pseudogenes originate from retrotransposition (25) Future studies should reveal whether this pseudogene is transcribed and where it is located in the genome.
Pseudogenes complicate the PCR analysis of (parts of) the original gene (23, 26, 28 as the fusion product. In any way primer sets to be used for internal control should be thoroughly tested to ascertain that no pseudogenes can be detected, thus to exclude false positive internal control results which may lead to false negative diagnoses. This is the only way RT-PCR translocation detection tests can be reliably implemented in routine diagnostic procedures.
